Literature DB >> 10430093

Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships.

J Califano1, P L Leong, W M Koch, C F Eisenberger, D Sidransky, W H Westra.   

Abstract

Patients with squamous cell carcinoma of the head and neck (HNSCC) often develop second carcinomas elsewhere in the upper aerodigestive tract. Some of these paired tumors share a common origin, reflecting the ability of a single progenitor cell to replicate, expand, and populate contiguous regions of the upper aerodigestive tract-a process referred to as clonal expansion. The geographical limitations of clonal expansion, however, have not been adequately addressed. For example, it is not known whether a neoplastic clone from the oral cavity, pharynx, or larynx can migrate to the esophagus. We compared paired tumors from 16 patients with HNSCC and a second squamous cell carcinoma of the esophagus (ESCC) for patterns of allelic loss on chromosomal arms 3p, 9p, and 17p. Losses at these loci occur early during neoplastic transformation of the respiratory tract. In 14 cases (87%), the paired tumors had discordant patterns of allelic loss, suggesting that these tumors were not clonally related. Conversely, two (13%) of the 16 paired tumors had identical genetic alterations, which suggests clonal expansion as the mechanism underlying tumor multifocality. One clone spread from the hypopharynx into the cervical esophagus, and the other spread from the tonsil to the distal esophagus. Although most second ESCCs appear to arise as independent neoplasms, a clonal population of neoplastic cells is capable of traveling across substantial distances to give rise to second tumors at different anatomical sites.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430093

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  23 in total

1.  Clonal origin and expansions in neoplasms: biologic and technical aspects must be considered together.

Authors:  Lucia Pozo-Garcia; Salvador J Diaz-Cano
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

Review 2.  Early events during neoplastic progression in Barrett's esophagus.

Authors:  Brian J Reid
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

3.  The oral cavity as a molecular mirror of lung carcinogenesis.

Authors:  David Sidransky
Journal:  Cancer Prev Res (Phila)       Date:  2008-06

Review 4.  The Stem Cell Network model: clinical implications in cancer.

Authors:  Rubén Cabanillas; José L Llorente
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-09-20       Impact factor: 2.503

Review 5.  Open questions and novel concepts in oral cancer surgery.

Authors:  Giancarlo Tirelli; Serena Zacchigna; Matteo Biasotto; Marco Piovesana
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-24       Impact factor: 2.503

6.  p53: Revealing the Unusual Suspect: a Study and Field Cancerization Minireview.

Authors:  Sandeep S Gupta; Devi Charan Shetty; Aadithya B Urs; Sowmya K
Journal:  Indian J Surg Oncol       Date:  2014-04-19

Review 7.  Molecular biology of squamous cell carcinoma of the head and neck.

Authors:  B Perez-Ordoñez; M Beauchemin; R C K Jordan
Journal:  J Clin Pathol       Date:  2006-05       Impact factor: 3.411

Review 8.  Field cancerisation in colorectal cancer: a new frontier or pastures past?

Authors:  Abhilasha Patel; Gyanendra Tripathi; Kishore Gopalakrishnan; Nigel Williams; Ramesh P Arasaradnam
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

9.  Chemopreventive trials in urologic cancer.

Authors:  Vahagn R Ashughyan; Sibylle Marihart; Bob Djavan
Journal:  Rev Urol       Date:  2006

10.  Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression.

Authors:  Xiaohong Li; Patricia C Galipeau; Carissa A Sanchez; Patricia L Blount; Carlo C Maley; Jessica Arnaudo; Daniel A Peiffer; Dmitry Pokholok; Kevin L Gunderson; Brian J Reid
Journal:  Cancer Prev Res (Phila)       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.